OTC Pharmaceuticals - Spain

Spain

Revenue in the OTC Pharmaceuticals market amounts to €2,790.00m in 2024. The market is expected to grow annually by 4.70% (CAGR 2024-2029).
The market's largest segment is the segment Cold & Cough Remedies with a market volume of €702.50m in 2024.
In global comparison, most revenue is generated in the United States (€37,700m in 2024).
In relation to total population figures, per person revenues of €58.77 are generated in 2024.
In the OTC Pharmaceuticals market, 12.7% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The OTC Pharmaceuticals market in Spain has experienced steady growth in recent years, driven by changing customer preferences and local special circumstances. Customer preferences in the OTC Pharmaceuticals market in Spain have shifted towards self-care and self-medication.

Increasingly, consumers are seeking convenient and accessible healthcare options, and are turning to over-the-counter products for minor ailments and preventive care. This trend is driven by factors such as busy lifestyles, rising healthcare costs, and a growing emphasis on wellness and prevention. As a result, there has been a growing demand for OTC medications that treat common conditions such as cold and flu, allergies, and digestive issues.

In addition to changing customer preferences, there are several trends in the OTC Pharmaceuticals market in Spain that are driving growth. One of the key trends is the increasing availability and accessibility of OTC medications. Pharmacies and drugstores are expanding their product offerings and making it easier for consumers to access OTC medications without a prescription.

This trend is supported by regulatory changes that have made it easier for certain medications to be sold over-the-counter. Another trend in the market is the growing popularity of natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are seeking natural alternatives to traditional medications.

This has led to an increase in the availability of natural and herbal OTC products in the market. Local special circumstances in Spain have also played a role in the development of the OTC Pharmaceuticals market. Spain has a well-developed healthcare system that provides universal coverage, but there are limitations to the system.

Long wait times and limited access to certain medications have led to a greater reliance on self-care and self-medication. Additionally, the country has a large aging population, which has increased the demand for OTC medications for chronic conditions such as arthritis and hypertension. Underlying macroeconomic factors have also contributed to the growth of the OTC Pharmaceuticals market in Spain.

The country has experienced economic recovery in recent years, which has led to increased consumer spending power. This has allowed consumers to allocate more of their budget towards healthcare and wellness products, including OTC medications. Additionally, the tourism industry in Spain has been booming, with millions of visitors each year.

This has created a demand for OTC medications from both domestic and international tourists. Overall, the OTC Pharmaceuticals market in Spain is experiencing growth due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As consumers continue to prioritize self-care and self-medication, and as the market continues to evolve to meet their needs, the OTC Pharmaceuticals market in Spain is expected to continue its upward trajectory.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.